Zoetis
5 Giralda Farms
Madison
New Jersey
07940
United States
Tel: 973660-7491
Website: http://www.zoetis.com/
221 articles about Zoetis
-
Zoetis to Participate in the Stifel 2019 Dental & Veterinary Conference
5/20/2019
Zoetis Inc. will participate in the Stifel 2019 Dental & Veterinary Conference on Wednesday, May 29, 2019, in New York, N.Y. Clint Lewis, Executive Vice President and Group President, International Operations, Commercial Development, Global Genetics, Aquatic Health and Human Medical Diagnostics will represent the company and respond to questions from analysts.
-
Forbes Names Zoetis One of America’s Best Employers for Fourth Year in a Row
4/17/2019
Named one of America’s Best Midsize Employers by Forbes Magazine for the fourth year in a row, ranking among the top 150 companies.
-
Zoetis to Host Webcast and Conference Call on First Quarter 2019 Financial Results
3/29/2019
Zoetis Inc. (NYSE:ZTS) will host a webcast and conference call at 8:30 a.m. (ET) on Thursday, May 2, 2019. Chief Executive Officer Juan Ramón Alaix and Executive Vice President and Chief Financial Officer Glenn David will review first quarter 2019 financial results and respond to questions from financial analysts during the call.
-
Zoetis Named a Top Company for Executive Women by NAFE
3/5/2019
The National Association for Female Executives (NAFE) Recognizes Zoetis for its Commitment to the Advancement of Women
-
Zoetis Reports Fourth Quarter and Full Year 2018 Results
2/14/2019
For Fourth Quarter 2018, Zoetis Reports Revenue of $1.6 Billion, Growing 7%, and Net Income of $345 Million, or $0.71 per
-
Zoetis Declares Second Quarter 2019 Dividend
2/12/2019
The Board of Directors of Zoetis Inc. has declared a second quarter 2019 dividend payable to holders of the company’s common stock of $0.164 per share.
-
Zoetis to Participate in the 37th Annual J.P. Morgan Healthcare Conference
12/18/2018
He is scheduled to present at 12:00 p.m. EST (9:00 a.m. PST).
-
Zoetis Announces Authorization of $2 Billion Share Repurchase Program
12/12/2018
Zoetis Inc. (NYSE: ZTS) today announced that its Board of Directors has authorized a $2 billion multi-year share repurchase program as part of its long-term capital allocation plans
-
Zoetis Announces Third Quarter 2018 Results
11/1/2018
Reports Revenue of $1.5 Billion, Growing 10%, and Net Income of $347 Million, or $0.71 per Diluted Share, Growing 16%, on a Reported Basis for Third Quarter 2018
-
Zoetis to Participate in the Credit Suisse 27th Annual Healthcare Conference
10/26/2018
Zoetis Inc. (NYSE:ZTS) will participate in the Credit Suisse 27th Annual Healthcare Conference on Tuesday, Nov. 13, 2018, in Scottsdale, Ariz. Glenn David, Executive Vice President and Chief Financial Officer, will represent the company and respond to questions from analysts.
-
Zoetis Declares Fourth Quarter 2018 Dividend
10/10/2018
The Board of Directors of Zoetis Inc. (NYSE:ZTS) has declared a fourth quarter 2018 dividend payable to holders of the company’s common stock of $0.126 per share. The dividend is to be paid on Monday, Dec. 3, 2018, to holders of record on Tuesday, Nov. 20, 2018.
-
Zoetis to Host Webcast and Conference Call on Third Quarter 2018 Financial Results
9/28/2018
Zoetis (NYSE:ZTS) will host a webcast and conference call at 8:30 a.m. (ET) on Thursday, Nov. 1, 2018.
-
Zoetis Named a Top Company for Working Mothers
9/25/2018
Zoetis recognized by Working Mother Magazine for its career advancement opportunities, female representation, work-life programs, and health and wellness benefits
-
Zoetis Announces Pricing of $1.5 Billion of Senior Notes
8/14/2018
Zoetis Inc. announced that it has agreed to sell $1.5 billion of senior notes
-
Zoetis Announces Second Quarter 2018 Results
8/2/2018
Reports Revenue of $1.4 Billion, Growing 12%, and Net Income of $384 Million
-
Zoetis and Abaxis Announce HSR Clearance for Zoetis’ Acquisition of Abaxis
7/6/2018
Zoetis’ previously-announced acquisition of Abaxis for US $83.00 per share in cash, or approximately $2.0 billion in aggregate.
-
Zoetis to Participate in the William Blair 2018 Growth Stock Conference
6/6/2018
Juan Ramón Alaix, Chief Executive Officer, will represent the company and respond to questions from analysts.
-
Regeneron and Zoetis Announce Collaboration to Research Antibody Therapies for Use in Animal Health
6/6/2018
Collaboration will also generate preclinical data to inform Regeneron's development of human medicines
-
Zoetis to Acquire Abaxis, a Leading Global Provider of Veterinary Point-of-Care Diagnostic Instruments
5/16/2018
Purchase price of US $83 per share in cash, or approximately $2.0 billion in aggregate
-
Anatara Announces Exclusive Global License Agreement with Zoetis
5/15/2018
Agreement represents the achievement of a major milestone for Anatara and its shareholders